Form 8-K - Current report:
SEC Accession No. 0001104659-22-072193
Filing Date
2022-06-17
Accepted
2022-06-17 08:33:18
Documents
13
Period of Report
2022-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218688d1_8k.htm   iXBRL 8-K 50483
2 EXHIBIT 3.1 tm2218688d1_ex3-1.htm EX-3.1 7885
  Complete submission text file 0001104659-22-072193.txt   238850

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20220616.xsd EX-101.SCH 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20220616_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20220616_pre.xml EX-101.PRE 22601
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2218688d1_8k_htm.xml XML 3718
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 221022477
SIC: 2834 Pharmaceutical Preparations